Moreover, when inactivation of RhoA signaling by transducing dominant-negative form of RhoA resulted in larger adenomas and decreased survival in a zebrafish model of KRAS-induced hepatic adenoma by rising AKT/S6 signaling and cyclin D1 [48]. The gene discussed is RHOA; the disease is adenoma.